Clinical trial Recruiting at 4 sites Observational Ages 55 to 110 Women only

Assessing frailty to predict outcomes in older gynecologic cancer patients

Official title: Frailty Assessments for Risk Assessment in Gynecologic Oncology Patients Undergoing Surgery and Chemotherapy

Run by Population Health Research Institute · NCT05738252 · Data updated 2026-11-12

This study is testing if checking for frailty before surgery can better predict recovery and complications for older women with gynecologic cancer compared to standard heart health checks.

More Frailty trials

Quick facts

Study typeObservational
Ages55 Years to 110 Years
SexWomen only
Enrollment280 (estimated)
SponsorPopulation Health Research Institute
Academic / other
Drugs / interventionschemotherapy, radiation
Locations4 sites (Hamilton, Ontario and 3 other locations)
StatusRecruiting
StartedJune 15, 2023
Main results expectedMay 2025
Study endsOctober 2025
Registry record updatedApril 16, 2025
Trial IDNCT05738252 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients aged 55 or older with confirmed or suspected gynecologic cancer who are scheduled for cytoreductive surgery.

Probably not a fit

Patients requiring urgent surgery, those with cognitive impairments, or those undergoing neoadjuvant radiation therapy may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate the effectiveness of preoperative frailty assessments using the Frailty Phenotype compared to traditional cardiovascular risk assessments in predicting postoperative outcomes for patients aged 55 and older with gynecologic cancer. By focusing on patients undergoing high-risk surgeries, the study seeks to fill knowledge gaps regarding postoperative recovery and complications. The findings could lead to improved clinical practices and inform future decision-making strategies in gynecologic oncology care.

Why it matters

Potential benefit: If successful, this study could enhance the prediction of postoperative outcomes, leading to better tailored care for older gynecologic cancer patients.

How similar studies have gone: While there is growing literature on frailty assessments in noncardiac surgery, studies specifically involving gynecologic oncology patients are limited and of low quality, making this approach relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age must be 55 years or older at registration
2. Must meet any one of the following criteria:

   1. Have stage II-IV ovarian or endometrial cancer, undergoing cytoreductive surgery via laparotomy, with or without neoadjuvant chemotherapy (NACT)
   2. Have any stage endometrial, uterine or cervical cancer planned for laparotomy where laparoscopy is deemed unfeasible/high-risk due to comorbidities
   3. Are undergoing laparotomy for pelvic mass, highly suspicious for malignancy; or
   4. Are undergoing laparotomy for gynecologic malignancy recurrence.

Exclusion Criteria:

1. Unable to provide informed consent
2. Require urgent surgery within 24 hours of first consultation to the Gynecological Oncology team
3. Are undergoing neoadjuvant radiation therapy
4. Have a previously documented history of dementia
5. Have cognitive, language, vision, or hearing impairment that impacts ability to understand the directions for the completion of the study instruments
6. Are participating in a clinical trial investigating a new systemic therapy

Where it's running

  • Juravinksi Hospital
    Hamilton, Ontario, Canada
    Recruiting
  • Credit Valley Hospital
    Mississauga, Ontario, Canada
    Recruiting
  • Sunnybrook
    Toronto, Ontario, Canada
    Recruiting
  • University Health Network
    Toronto, Ontario, Canada
    Recruiting

Study contacts

  • Principal investigator: Maura Marcucci, MD — Population Health Research Institute
  • Study coordinator: Julie My Van Nguyen, MD
  • Email: nguyenjmv@HHSC.CA
  • Phone: 905-521-2100

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.